Adverse drug effects; clinical trials and real... - CLL Support

CLL Support

22,474 members38,610 posts

Adverse drug effects; clinical trials and real life - What we can learn from Pradaxa

AussieNeil profile image
AussieNeilAdministrator
1 Reply

From the University of Sydney, Australia, Wendy Lipworth, Senior Research Fellow, Bioethics and Ian Kerridge, Associate Professor in Bioethics & Director, Centre for Values and Ethics and the Law in Medicine, provide insights into the challenges of identifying adverse drug effects both during trials and after a drug is approved, along with the difficulties of comparing the side effect risks of new and established drugs. The drug in question, Pradaxa, may also be of relevance to some in our community, as it is prescribed to people with abnormal heart rhythms and other diseases that cause blood clots.

"Even the best-designed clinical trials provide only preliminary information about adverse drug effects.

This is not ideal but it can’t be helped because clinical trials are, by necessity, artificial set-ups, tightly controlled in terms of patient selection, drug dosages, length of treatment, monitoring, and so on. They don’t, and can’t, reflect the vagaries and complexities of real-world prescribing practice and patient behaviour.

So it’s almost inevitable that at least some new adverse effects will emerge after a drug has been approved for marketing."

This is a longish read, but isn't all that technical. I'd highly recommend it to anyone anticipating going on a trial, in a trial, or starting on a newly approved drug. It certainly makes you even more appreciative of those that face the unknowns of new medications during trials and in the early days after approval...

theconversation.com/theres-...

Neil

Photo: Australian Golden Whistler

Written by
AussieNeil profile image
AussieNeil
Administrator
To view profiles and participate in discussions please or .
Read more about...
1 Reply
Cllcanada profile image
CllcanadaTop Poster CURE Hero

That quote should be required reading for patients beginning treatment with new drugs like Imbruvica (ibrutinib), Gazyva (obinutuzimab) and Zydelig (idelalisib) .

Everyone is different, and adverse events do occur. Hopefully doctors are on the ball, but patients can also report problems to drug licensing authorities...in most countries.

In the UK it is called Yellow Card... like soccer... ya know... I have never been carded... :)

yellowcard.mhra.gov.uk

In the USA ...Medwatch

fda.gov/Safety/MedWatch/

Canada MedEffect

hc-sc.gc.ca/dhp-mps/medeff/...

Australia TGA

tga.gov.au/hp/problem-medic...

But I'm probably whistling in the wind... ;-) great photo... oh for a longer lens!

You may also like...

Covid-19: What, if anything, can we learn from integrative oncology experts?

Cardiac side effects from drugs: Predictable?

our therapy drugs i.e. Rituxan & Ibrutinib, have been associated with cardiac side effects for some...

Life after fcr...what can we expect?

How often should we be monitored? ... What side effects of FCR may we have long term? Nic asked...

Hi everyone , how far do you think we are away from not using FCR has the first line treatment , and drugs such as ibrutinib or cal - 101

ibrutinib trials has began in the uk also consultants going through NICE to make this drug available

Expert Perspective on Key Trial Updates in Treatment of CLL: What You Need to Know From ASCO/EHA/ICML 2021

conferences have provided reassuring updates and new data for hematologists who treat patients with...